Case Report: (18)F-PSMA-1007 PET/CT Avid Solitary Penile Metastasis of Castration-Resistant Prostate Cancer With a PSA of 0.072 ng/ml

Penile metastasis of prostate cancer is rare, with a poor prognosis, and only a limited number of relevant cases have been reported so far. With the application of (18)F-PSMA-1007 PET/CT, the biochemical recurrence of prostate cancer can be detected at an early stage for providing important evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yongliang, Li, Yanmei, Dong, Siying, Chen, Jian, Yang, Pengfei, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067612/
https://www.ncbi.nlm.nih.gov/pubmed/35530336
http://dx.doi.org/10.3389/fonc.2022.881896
Descripción
Sumario:Penile metastasis of prostate cancer is rare, with a poor prognosis, and only a limited number of relevant cases have been reported so far. With the application of (18)F-PSMA-1007 PET/CT, the biochemical recurrence of prostate cancer can be detected at an early stage for providing important evidence, facilitating clinical decision-making. Here, we have reported a case of solitary penile metastatic recurrence in the context of mild PSA progression (PSA: 0.072 ng/ml). This case highlights the preferable sensitivity of (18)F-PSMA-1007 PET/CT imaging in prostate cancer.

Ejemplares similares